← Open Payments lookup

MIRNA CLERIE: Open Payments

NPI 1942447974 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$782 in 23 payments from 12 companies in 2025. Trend: 2023 $438 · 2024 $662 · 2025 $782

Food & beverage: $782
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$176
Daiichi Sankyo Inc.2$157
Novartis Pharmaceuticals Corporation5$134
Takeda Pharmaceuticals U.S.A., Inc.3$79
Merck Sharp & Dohme LLC2$44
Regeneron Healthcare Solutions, Inc.1$39
Janssen Biotech, Inc.1$35
Invivyd Inc1$29
Agios Pharmaceuticals, Inc.1$26
Lilly USA, LLC1$23

Products named: Enhertu, DATROWAY, KISQALI, PLUVICTO, KEYTRUDA, LIBTAYO, ERLEADA, FRUZAQLA.

Industry payments across DC — which companies pay providers there.